Insufficient scRNA-seq data for expression of FGFBP3 at single-cell level.
Insufficient scRNA-seq data for expression of FGFBP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 385.40 | 2640 / 2642 | 100% | 28.69 | 705 / 705 |
prostate | 100% | 205.29 | 245 / 245 | 100% | 5.02 | 501 / 502 |
thymus | 100% | 275.04 | 653 / 653 | 98% | 3.87 | 591 / 605 |
adrenal gland | 100% | 150.57 | 257 / 258 | 94% | 5.05 | 216 / 230 |
pancreas | 96% | 115.08 | 315 / 328 | 88% | 2.13 | 157 / 178 |
ovary | 98% | 149.29 | 177 / 180 | 83% | 2.34 | 359 / 430 |
intestine | 96% | 114.85 | 927 / 966 | 86% | 2.29 | 452 / 527 |
bladder | 100% | 168.14 | 21 / 21 | 80% | 2.38 | 402 / 504 |
stomach | 91% | 82.62 | 328 / 359 | 79% | 1.72 | 227 / 286 |
breast | 98% | 135.49 | 451 / 459 | 70% | 1.98 | 784 / 1118 |
uterus | 98% | 138.41 | 166 / 170 | 69% | 2.07 | 315 / 459 |
esophagus | 92% | 88.72 | 1333 / 1445 | 64% | 1.43 | 118 / 183 |
skin | 98% | 129.99 | 1776 / 1809 | 57% | 1.38 | 268 / 472 |
lung | 83% | 86.31 | 478 / 578 | 70% | 1.79 | 813 / 1155 |
kidney | 91% | 96.71 | 81 / 89 | 45% | 0.78 | 407 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.84 | 1 / 1 |
spleen | 100% | 143.63 | 240 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 146.18 | 1311 / 1335 | 0% | 0 | 0 / 0 |
adipose | 90% | 93.94 | 1080 / 1204 | 0% | 0 | 0 / 0 |
muscle | 84% | 81.10 | 674 / 803 | 0% | 0 | 0 / 0 |
heart | 70% | 52.75 | 604 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 66% | 1.12 | 19 / 29 |
liver | 31% | 18.16 | 71 / 226 | 32% | 0.58 | 129 / 406 |
tonsil | 0% | 0 | 0 / 0 | 42% | 0.79 | 19 / 45 |
peripheral blood | 35% | 20.92 | 324 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 30% | 0.58 | 24 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045743 | Biological process | positive regulation of fibroblast growth factor receptor signaling pathway |
GO_0007267 | Biological process | cell-cell signaling |
GO_0043117 | Biological process | positive regulation of vascular permeability |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0008201 | Molecular function | heparin binding |
GO_0017134 | Molecular function | fibroblast growth factor binding |
GO_0019838 | Molecular function | growth factor binding |
Gene name | FGFBP3 |
Protein name | Fibroblast growth factor-binding protein 3 (FGF-BP3) (FGF-binding protein 3) (FGFBP-3) |
Synonyms | PSEC0101 C10orf13 |
Description | FUNCTION: Heparin-binding protein which binds to FGF2, prevents binding of FGF2 to heparin and probably inhibits immobilization of FGF2 on extracellular matrix glycosaminoglycans, allowing its release and subsequent activation of FGFR signaling which leads to increased vascular permeability. . |
Accessions | ENST00000311575.6 Q8TAT2 |